Ann Lab Med.  2013 May;33(3):200-202. 10.3343/alm.2013.33.3.200.

A Case of Clostridium difficile Bacteremia in a Patient with Loop Ileostomy

• Choi JL
• Kim BR
• Kim JE
• Woo KS
• Kim KH
• Kim JM
• Lee SE
• Han JY

• KMID: 1781327
• DOI: http://doi.org/10.3343/alm.2013.33.3.200

Abstract

Clostridium difficile, an anaerobic, spore-forming, gram-positive, rod-shaped bacterium, is the most common nosocomial pathogen causing pseudomembranous colitis. C. difficile is not intrinsically invasive and rarely infects extraintestinal sites. The bacterium, therefore, is not commonly detected in blood cultures. Here, we report a case of C. difficile bacteremia in a patient who had underwent loop ileostomy because of rectal obstruction following metastatic colon cancer originated from prostate cancer.

Keyword

Clostridium difficile; Bacteremia; Loop ileostomy

MeSH Terms

Anti-Bacterial Agents/*therapeutic use
Bacteremia/*drug therapy
Clostridium difficile/genetics/*isolation & purification
Colonic Neoplasms/pathology/secondary
Enterocolitis, Pseudomembranous/drug therapy/microbiology
Humans
Ileostomy
Male
Middle Aged
Prostatic Neoplasms/pathology
RNA, Ribosomal, 16S/chemistry/genetics
Sequence Analysis, RNA
Anti-Bacterial Agents
RNA, Ribosomal, 16S

Reference

1. Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev. 2005; 18:247–263. PMID: 15831824.

2. Tonna I, Welsby PD. Pathogenesis and treatment of Clostridium difficile infection. Postgrad Med J. 2005; 81:367–369. PMID: 15937201.

3. García-Lechuz JM, Hernangómez S, Juan RS, Peláez T, Alcalá L, Bouza E. Extra-intestinal infections caused by Clostridium difficile. Clin Microbiol Infect. 2001; 7:453–457. PMID: 11591212.

4. Jacobs A, Barnard K, Fishel R, Gradon JD. Extracolonic manifestations of Clostridium difficile infections. Presentation of 2 cases and review of the literature. Medicine. 2001; 80:88–101. PMID: 11307591.

5. Cho SM, Lee JJ, Yoon HJ. Clinical risk factors for Clostridium difficile-associated diseases. Braz J Infect Dis. 2012; 16:256–261. PMID: 22729193.

6. Lee JS, Kim GT, Yang MJ, Seo JH. A case of reactive arthritis in a patient with Clostridium difficile diarrhea. J Korean Rheum Assoc. 2009; 16:43–47.

7. Spencer RC, Courtney SP, Nicol CD. Polymicrobial septicaemia due to Clostridium difficile and Bacteroides fragilis. Br Med J (Clin Res Ed). 1984; 289:531–532.

8. Lee NY, Huang YT, Hsueh PR, Ko WC. Clostridium difficile bacteremia, Taiwan. Emerg Infect Dis. 2010; 16:1204–1210. PMID: 20678312.

9. McGill F, Fawley WN, Wilcox MH. Monomicrobial Clostridium difficile bacteraemias and relationship to gut infection. J Hosp Infect. 2011; 77:170–171. PMID: 21129818.

10. Hemminger J, Balada-Llasat JM, Raczkowski M, Buckosh M, Pancholi P. Two case reports of Clostridium difficile bacteremia, one with the epidemic NAP-1 strain. Infection. 2011; 39:371–373. PMID: 21509425.

11. Kang HJ, Kwak DH, Choi MH, Kim HT, Kwak TY, Lee HC, et al. Three Cases of Pseudomembranous Colitis with Hematochezia. Korean J Gastrointest Endosc. 2011; 42:410–414.

12. Pai H. Current epidemiology and treatment of Clostridium difficile infection. Infect Chemother. 2010; 42:362–368.

13. Lee YJ, Choi MG, Lim CH, Jung WR, Cho HS, Sung HY, et al. Change of Clostridium difficile colitis during recent 10 years in Korea. Korean J Gastroenterol. 2010; 55:169–174. PMID: 20357527.

14. Lee JH, Lee SY, Kim YS, Park SW, Park SW, Jo SY, et al. The incidence and clinical features of Clostridium difficile infection; Single center study. Korean J Gastroenterol. 2010; 55:175–182. PMID: 20357528.

15. Kim H, Lee Y, Moon HW, Lim CS, Lee K, Chong Y. Emergence of Clostridium difficile ribotype 027 in Korea. Korean J Lab Med. 2011; 31:191–196. PMID: 21779194.